Visual, auditory, and somatosensory evoked responses were recorded from six age groups of Down's syndrome persons and age and sex-matched nonretarded individuals ranging in age from 5 to 62 years and assigned to groups on the basis of observable signs of development and aging. Results indicated that, regardless of stimulus modality, the amplitude of late wave components was dramatically larger for Down's syndrome than for the nonretarded subjects. Where obvious amplitude reduction occurred with maturation and aging among nonretarded subjects, amplitude changes were generally absent among Down's syndrome subjects. The findings for Down's syndrome persons were discussed in terms of deficits in central inhibition and abnormalities in neuronal excitability to different levels of stimulus intensity.

Download full-text PDF

Source

Publication Analysis

Top Keywords

down's syndrome
20
evoked responses
8
syndrome nonretarded
8
syndrome persons
8
nonretarded subjects
8
down's
5
syndrome
5
life span
4
span changes
4
changes averaged
4

Similar Publications

Background: Enamel renal gingival syndrome (ERS) is a genetic disorder caused by mutations in the FAM20A gene located on long arm of chromosome 17. It is characterized by presence of intra-oral features like hypoplastic type of amelogenesis imperfecta, fibromatosis of gingiva and nephrocalcinosis in addition to delayed eruption. The oral phenotype is evident in childhood, whereas the renal involvement is clinically silent at this age and requires further investigation for detection at later age.

View Article and Find Full Text PDF

Approximately one in every 800 children is born with the severe aneuploid condition of Down Syndrome, a trisomy of chromosome 21. Low blood pressure (hypotension) is a common condition associated with DS and can have a significant impact on exercise tolerance and quality of life. Little is known about the factors driving this hypotensive phenotype and therefore therapeutic interventions are limited.

View Article and Find Full Text PDF

Background: Almost half of individuals born with Down syndrome (DS) have congenital heart defects (CHDs). Yet, little is known about the health and healthcare needs of adults with CHDs and DS. Therefore, we examined comorbidities and healthcare utilization of this population.

View Article and Find Full Text PDF

Introduction: Aging adults with Down syndrome (DS) accumulate Alzheimer's disease (AD) neuropathology, including amyloid beta plaques and neurofibrillary tangles, by age 40.

Methods: We present findings from an individual with DS who remained cognitively stable despite AD neuropathology. Clinical assessments, fluid biomarkers, neuroimaging, and neuropathological examinations were conducted to characterize her condition.

View Article and Find Full Text PDF

New insights regarding the early emergence of phenotypic patterns of strength and challenge in neurogenetic conditions afford the possibility of personalized, anticipatory intervention approaches. The development of novel 'syndrome-informed' interventions, however, should incorporate principles that will maximize the utility of intervention activities for as many children with a given neurogenetic condition as possible. This review examines several of these dimensions, including the use of community-engaged frameworks to ensure feasibility and acceptability of novel interventions; the development of cross-nationally valid approaches that can be readily translated into other languages and cultural contexts; and the use of adaptive interventions designs that allow for the tailoring of intervention pathways based on key child dimensions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!